Description
Acabrunat (Acalabrutinib 100 mg) capsule, a kinase inhibitor is primarily used in the treatment of certain types of blood cancers. It is a targeted therapy that belongs to a class of medicines known as Bruton’s Tyrosine Kinase (BTK) inhibitors. Here’s a look at its uses:
- Mantle Cell Lymphoma (MCL): Acalabrutinib 100 mg is used for the treatment of Mantle Cell Lymphoma, especially in adult patients who have already undergone at least one prior treatment. MCL is a rare and aggressive form of non-Hodgkin lymphoma, and this medicine works by interfering with the growth of cancer cells, slowing down or stopping their proliferation.
- Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): These are common types of leukemia in adults. Treatment with Acalabrutinib is used as a monotherapy or in combination with other medications to treat CLL and SLL. By targeting BTK, the drug helps in controlling the spread and multiplication of cancer cells, which can enhance the patient’s quality of life.
Overall, Acalabrutinib capsules offer a vital therapeutic option for patients with specific blood cancers by targeting and inhibiting the growth of cancerous cells. Patients taking this medicinal product should be under the care of a healthcare professional to monitor for efficacy and manage potential side effects.